참고문헌
- Velleca A, Shullo MA, Dhital K, et al. The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2023;42:e1-141.
- Chang DH, Youn JC, Dilibero D, Patel JK, Kobashigawa JA. Heart transplant immunosuppression strategies at Cedars-Sinai Medical Center. Int J Heart Fail 2020;3:15-30.
- Rao RA, Kransdorf EP, Patel JK, Kobashigawa JA, Kittleson MM. How to approach HLA sensitization in heart transplant candidates. JACC Heart Fail 2023;11:469-75.
- Chih S, McDonald M, Dipchand A, et al. Canadian Cardiovascular Society/Canadian Cardiac Transplant Network position statement on heart transplantation: patient eligibility, selection, and posttransplantation care. Can J Cardiol 2020;36:335-56.
- Kransdorf EP, Kittleson MM, Patel JK, Pando MJ, Steidley DE, Kobashigawa JA. Calculated panel-reactive antibody predicts outcomes on the heart transplant waiting list. J Heart Lung Transplant 2017;36:787-96.
- Kim D, Choi JO, Cho YH, et al. Impacts of pre-transplant panel-reactive antibody on post-transplantation outcomes: a study of nationwide heart transplant registry data. Korean Circ J 2024;54:325-35.
- Nwakanma LU, Williams JA, Weiss ES, Russell SD, Baumgartner WA, Conte JV. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg 2007;84:1556-62.
- Lim JH, Lee SY, Ju MH, et al. Direct extracorporeal membrane oxygenation bridged heart transplantation: the importance of multi-organ failure. Int J Heart Fail 2023;5:91-9.
- Hong JA, Kim AR, Kim MJ, et al. Comparison of veno-arterial extracorporeal membrane oxygenation configurations for patients listed for heart transplantation. Korean Circ J 2023;53:535-47.
- Colvin M, Smith JM, Skeans MA, et al. OPTN/SRTR 2015 Annual Data Report: Heart. Am J Transplant 2017;17 Suppl 1:286-356.